A new study says the US has the highest number of mega-mergers and acquisitions among major economies, and that the global economy has slowed by about 1% in the past year.
But that doesn’t mean the US isn’t booming.
The global economy is booming and expanding, but we have been hitting a wall in terms of productivity growth, according to a report from the Federal Reserve Bank of New York.
The study analyzed mergers and acquisition trends between the US, Canada, Australia and the European Union and found that the number of merger and acquisition deals each year has grown by about $1 trillion over the past decade.
That is roughly double the annual growth rate in the US and Canada.
The report said that US mergers accounted for roughly three-quarters of the total number of deals in the global marketplace in 2015, up from about two-thirds in 2008.
Canada accounted for about half of the US deals, up slightly from just under a third in 2008, and Australia and Europe together accounted for nearly a third of deals, with China accounting for nearly half.
The global economy hit a wall, the report said, in part because of the combination of a slowing global economy, the impact of the global financial crisis on the US economy and the global recession that hit the world economy in 2008 and 2009.
In recent years, there has been a lot of pressure on the megacorporations to move faster to improve productivity growth.
But, the Fed said, the slowdowns have slowed, and so has the pace of mergers.
The report said the overall trend was a good sign that mergers are going well.
In particular, the number and size of merges in the first half of 2016 is the highest on record.
The Fed said the pace is “not unusual.”
In its statement, the bank said it’s “increasingly apparent that the pace and extent of merger activity has slowed, albeit not entirely.”
The bank added that it expects the US will be the fastest-growing major economy in 2016.
It said that while there has not been a major corporate mergers or acquisitions in the United States in recent years (other than those between Pfizer and Allergan), it is likely that some of the recent mergers may be due to increased competition from China and elsewhere.